Regions Financial Corp Gilead Sciences, Inc. Transaction History

Regions Financial Corp

$13.8 Billion
Q3 2024

A detailed history of Regions Financial Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Regions Financial Corp holds 11,684 shares of GILD stock, worth $1.08 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,684

Previous 12,198 4.21%

Holding current value

$1.08 Million

Previous $836,000 17.11%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $34,227 - $43,170	-514 Reduced 4.21%	11,684 $979,000
Q2 2024 Jul 31, 2024	SELL	$63.15 - $72.88 $322,254 - $371,906	-5,103 Reduced 29.5%	12,198 $836,000
Q1 2024 Apr 23, 2024	SELL	$71.58 - $87.29 $74,443 - $90,781	-1,040 Reduced 5.67%	17,301 $1.27 Million
Q4 2023 Feb 06, 2024	SELL	$73.27 - $83.09 $120,602 - $136,766	-1,646 Reduced 8.24%	18,341 $1.49 Million
Q3 2023 Nov 01, 2023	SELL	$73.94 - $80.67 $14,196 - $15,488	-192 Reduced 0.95%	19,987 $1.5 Million
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $122,528 - $139,760	-1,612 Reduced 7.4%	20,179 $1.56 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $69,501 - $79,183	-899 Reduced 3.96%	21,791 $1.81 Million
Q4 2022 Feb 03, 2023	BUY	$62.32 - $89.47 $33,403 - $47,955	536 Added 2.42%	22,690 $1.95 Million
Q3 2022 Nov 03, 2022	SELL	$59.54 - $68.01 $28,638 - $32,712	-481 Reduced 2.13%	22,154 $1.37 Million
Q2 2022 Jul 25, 2022	SELL	$57.72 - $65.01 $112,784 - $127,029	-1,954 Reduced 7.95%	22,635 $1.4 Million
Q1 2022 Apr 25, 2022	SELL	$57.92 - $72.58 $8,919 - $11,177	-154 Reduced 0.62%	24,589 $1.46 Million
Q4 2021 Jan 31, 2022	SELL	$64.88 - $73.64 $157,269 - $178,503	-2,424 Reduced 8.92%	24,743 $1.8 Million
Q3 2021 Nov 04, 2021	SELL	$67.69 - $73.03 $161,982 - $174,760	-2,393 Reduced 8.1%	27,167 $1.9 Million
Q2 2021 Jul 27, 2021	SELL	$63.47 - $69.35 $821,936 - $898,082	-12,950 Reduced 30.46%	29,560 $2.04 Million
Q1 2021 Jun 02, 2021	SELL	$60.0 - $68.46 $905,700 - $1.03 Million	-15,095 Reduced 26.2%	42,510 $2.75 Million
Q4 2020 Feb 05, 2021	SELL	$56.65 - $64.55 $970,924 - $1.11 Million	-17,139 Reduced 22.93%	57,605 $3.36 Million
Q3 2020 Oct 15, 2020	SELL	$62.1 - $78.08 $676,952 - $851,150	-10,901 Reduced 12.73%	74,744 $4.72 Million
Q2 2020 Jul 27, 2020	SELL	$72.34 - $84.0 $4.69 Million - $5.45 Million	-64,884 Reduced 43.1%	85,645 $6.59 Million
Q1 2020 Apr 29, 2020	SELL	$62.63 - $80.22 $33.3 Million - $42.7 Million	-531,666 Reduced 77.93%	150,529 $11.3 Million
Q4 2019 Feb 03, 2020	SELL	$61.62 - $67.78 $1.08 Million - $1.19 Million	-17,541 Reduced 2.51%	682,195 $44.3 Million
Q3 2019 Oct 24, 2019	BUY	$62.51 - $69.0 $1.9 Million - $2.1 Million	30,401 Added 4.54%	699,736 $44.4 Million
Q2 2019 Jul 19, 2019	BUY	$61.87 - $69.38 $1.73 Million - $1.93 Million	27,885 Added 4.35%	669,335 $45.2 Million
Q1 2019 Apr 19, 2019	BUY	$62.53 - $70.05 $8.34 Million - $9.34 Million	133,381 Added 26.25%	641,450 $41.7 Million
Q4 2018 Jan 28, 2019	BUY	$60.54 - $79.0 $25 Million - $32.6 Million	412,133 Added 429.59%	508,069 $31.8 Million
Q3 2018 Oct 22, 2018	BUY	$71.28 - $78.92 $1.23 Million - $1.36 Million	17,254 Added 21.93%	95,936 $7.41 Million
Q2 2018 Jul 26, 2018	BUY	$64.88 - $75.68 $576,264 - $672,189	8,882 Added 12.72%	78,682 $5.57 Million
Q1 2018 Apr 18, 2018	SELL	$72.84 - $88.8 $186,106 - $226,884	-2,555 Reduced 3.53%	69,800 $5.26 Million
Q4 2017 Jan 18, 2018	BUY	$71.15 - $83.52 $128,994 - $151,421	1,813 Added 2.57%	72,355 $5.18 Million
Q3 2017 Oct 23, 2017	BUY	$72.11 - $85.47 $5.09 Million - $6.03 Million	70,542	70,542 $5.72 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

993M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Regions Financial Corp with notifications on news.

Account

Regions Financial Corp Gilead Sciences, Inc. Transaction History